Navigation Links
Lead Plaintiff's Attorney In Forest Pharmaceuticals Case Says $313 Million Award Is 'Tip of the Iceberg' of Future Off-Label Marketing Lawsuits
Date:9/17/2010

SHORT HILLS, N.J., Sept. 17 /PRNewswire/ -- Fresh off his victory for a whistle-blower in the Forest Pharmaceuticals, Inc. lawsuit, attorney David Stone is setting his sights on the billions of dollars of settlements he expects awarded in future legal actions involving off-labeling marketing practices.

"The award of $313 million in the Forest Pharmaceuticals case is just the tip of the iceberg in comparison to the amount of off-label marketing kick-back settlements we'll see in the future," Stone said. "Pharmaceutical companies are under increasing competitive pressures. Unfortunately, in their attempts to increase product sales, many are engaging in deceptive and illegal conduct, which has endangered patients' health and even their lives, as well as cost taxpayers billions of healthcare dollars."

Stone, managing partner of Short Hills, NJ-based law firm Stone & Magnanini LLP, represented a physician who originally brought Forest Pharmaceuticals' illegal marketing practices to the government's attention in a 2001 False Claims Act lawsuit. Stone previously served as head of the False Claims Act department for renowned litigator, David Boies, and headed that firm's New Jersey office.

Stone explained that the Federal government is focusing more broadly on pharmaceutical industry marketing practices. The Department of Justice and the Office of the Inspector General are scrutinizing practices tied to relations between drug makers and the physicians who endorse their products; the content and distribution of product promotional materials; and the complex inter-relationship of manufacturers, physicians, insurers and others in the drug-delivery chain.

Forest Pharmaceuticals recently agreed to settle civil and criminal claims based on off-label marketing and kick-backs to physicians for the antidepressant drugs Celexa and Lexapro, and Levothoid, a drug used to treat hypothyroidism, for more than $313 million.  

Stone & Magnanini LLP specializes in False Claims Act cases in the pharmaceutical fraud area – initiating legal actions on behalf of individuals, as well as for third-party payers such as insurance companies and HMOs. The firm also works with pharmaceutical companies to review their existing practices and procedures in light of current DOJ and OIG policy-related initiatives. Visit www.StoneMagnaLaw.com.

Contact:  Mark Clemente, Steinreich Communications, 201-498-1600, mclemente@scompr.com


'/>"/>
SOURCE Stone & Magnanini LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Plaintiffs and Novartis Pharmaceuticals Corporation, a US Subsidiary of Novartis AG, Agree to Resolve All Gender Discrimination Claims Associated With Class Action
2. Fort Worth Attorney Dwain Dent Comments on Final Judgment in Case That Left Hundreds of Babies Dead or Injured
3. Remarks as Prepared for Delivery By Attorney General Eric Holder at the AstraZeneca Settlement Announcement
4. Relators Attorneys Comment On AtriCure/DOJ Proposed Settlement
5. Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
6. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
9. NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood
10. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
11. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... Bio-Techne Corporation has partnered with Brazil ... diagnostic tool for the veterinary market. The PARATEST ... the only non-toxic, biodegradable fixative available to the ... Bio-Techne,s Diagnostic Division in Devens, MA ... manufacturing, and packaging capabilities to bring this unique ...
(Date:3/1/2017)... Research and Markets has announced the addition of ... & Infectious Diseases" report to their offering. ... Did you know? - ... Genomic Health, Inc.. - Beijing Wantai Biological Pharmacy,s Beijing ... infectious diseases diagnostics in China . - MDxHealth ...
(Date:3/1/2017)... HOUSTON , March 1, 2017  The Welch ... funding for basic research, today announced that Drs. ... are the 2017 recipients of the Norman ... being recognized as ,rising stars, having contributed significant scientific ... the first time in the 15 years of the ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... March 01, 2017 , ... ... of eating disorders, is pleased to announce the opening of residential services, in ... this week, Aloria Health will accept adult clients for residential treatment. , ...
(Date:3/1/2017)... , ... March 01, 2017 , ... Hennessey Performance (HPE) today announced its VelociRaptor 600 ... Ford EcoBoost 3.5L twin turbo V6 engine from 450 bhp and 510 lb-ft of torque ... a 0-60 mph time of just 4.2 seconds while running down the ¼ mile in ...
(Date:3/1/2017)... ... March 01, 2017 , ... Both incentives ... Supplemental Nutrition Assistance Program (SNAP) can reduce food insecurity. Findings are presented in ... the American Journal of Preventive Medicine . , Researchers examined data from two ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... the release of its 2017 update to Compass, the popular online learning ... advisors. , Suitable for standardizing both new-hire on-boarding and annual competency-validation, Compass ...
(Date:3/1/2017)... ... 01, 2017 , ... Award-winning medical group Allied Anesthesia today announced that, as ... nations, averaging more than one trip per year since 1998. Char was named the ... features the details of his charitable work. Char has been an Allied Anesthesiologist since ...
Breaking Medicine News(10 mins):